Correlation Between Johnson Johnson and BriaCell Therapeutics
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and BriaCell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and BriaCell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and BriaCell Therapeutics Corp, you can compare the effects of market volatilities on Johnson Johnson and BriaCell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of BriaCell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and BriaCell Therapeutics.
Diversification Opportunities for Johnson Johnson and BriaCell Therapeutics
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Johnson and BriaCell is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and BriaCell Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BriaCell Therapeutics and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with BriaCell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BriaCell Therapeutics has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and BriaCell Therapeutics go up and down completely randomly.
Pair Corralation between Johnson Johnson and BriaCell Therapeutics
Considering the 90-day investment horizon Johnson Johnson is expected to under-perform the BriaCell Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Johnson Johnson is 12.04 times less risky than BriaCell Therapeutics. The stock trades about -0.12 of its potential returns per unit of risk. The BriaCell Therapeutics Corp is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 32.00 in BriaCell Therapeutics Corp on August 30, 2024 and sell it today you would earn a total of 2.50 from holding BriaCell Therapeutics Corp or generate 7.81% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 95.45% |
Values | Daily Returns |
Johnson Johnson vs. BriaCell Therapeutics Corp
Performance |
Timeline |
Johnson Johnson |
BriaCell Therapeutics |
Johnson Johnson and BriaCell Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Johnson Johnson and BriaCell Therapeutics
The main advantage of trading using opposite Johnson Johnson and BriaCell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, BriaCell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BriaCell Therapeutics will offset losses from the drop in BriaCell Therapeutics' long position.Johnson Johnson vs. Pharvaris BV | Johnson Johnson vs. Brinker International | Johnson Johnson vs. Alcoa Corp | Johnson Johnson vs. Direxion Daily FTSE |
BriaCell Therapeutics vs. Bright Minds Biosciences | BriaCell Therapeutics vs. HP Inc | BriaCell Therapeutics vs. Intel | BriaCell Therapeutics vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |